FlowCam uses Flow Imaging Microscopy (FIM) to characterize particles in liquid biopharmaceutical formulations. There are ...
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRSKAN with significant ...
This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...
Trump’s nominee to lead the Centers for Medicare and Medicaid Services is entangled in another potential conflict of interest ...
Inno Madness bracket is live. Check out which Chicago startups made the cut this year and get your votes in now.
3d
VnExpress International on MSNWatson-Marlow Fluid Technology Solutions offers Certa Sine energy-efficient, cost-saving pumpsWatson-Marlow Fluid Technology Solutions (WMFTS) will showcase its peristaltic and sinusoidal pumps at Propak Vietnam, focusing on optimizing efficiency, increasing productivity, and reducing energy ...
6d
Fintel on MSNEvercore ISI Group Initiates Coverage of Repligen (RGEN) with In-Line RecommendationFintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Repligen (NasdaqGS:RGEN) with a In-Line ...
HashKey Chain announced that the tokenized USD Money Market Fund, "CPIC Estable MMF", initiated and managed by CPIC Investment Management (H.K.) Co, Ltd, was successfully deployed on HashKey Chain, ...
Allied Market Research published a report, titled, "HVAC Pump Market by Pump Type (Booster pumps, Circulating pumps, Centrifugal pumps, and Others), Product Type (Single stage and Multi stage), End ...
Learn more about whether Bruker Corporation or Stevanato Group S.p.A. is a better investment based on AAII's A+ Investor ...
The Biopharmaceutical Development segment ... such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing ...
5d
Zacks Small Cap Research on MSNTELO Study Shows Cancer-Related BreakthroughTELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results